RecruitingNCT06759428

Registry of Chronic Subdural Hematoma


Sponsor

Erasmus Medical Center

Enrollment

1,500 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions: 1. What are the characteristics of patients with CSDH when they are diagnosed? 2. What treatments do patients with CSDH receive? 3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status? Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients diagnosed with CSDH
  • years or older

Exclusion Criteria1

  • Patients who do not consent to participate in the registry

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Amsterdam UMC

Amsterdam, Netherlands

Erasmus MC

Rotterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06759428


Related Trials